

          1. dying state (i.e. survival time is less than 24 hours);

          2. progressive malignant tumor with life expectancy less than 6 months;

          3. immunosuppressive status(patients using immunosuppressants or chemotherapeutic drugs)

          4. underlying diseases requiring long-term glucocorticoid treatment in the past 6 months
             or short-term glucocorticoid therapy in the past 4 weeks;

          5. pregnancy

          6. patients with glucocorticoid taboos
      